tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (PL:RVU)
:RVU
Poland Market

Ryvu Therapeutics SA (RVU) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

RVU Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Ryvu
Therapeutics SA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RVU Stock 12 Month Forecast

There Are No Analyst Ratings for PL:RVU In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

RVU Financial Forecast

RVU Earnings Forecast

The previous quarter’s earnings for RVU were -zł1.07.
The previous quarter’s earnings for RVU were -zł1.07.

RVU Sales Forecast

Next quarter’s sales forecast for RVU is zł22.10M with a range of zł21.80M to zł22.40M. The previous quarter’s sales results were zł14.92M. RVU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.06% of the time in the same period. In the last calendar year RVU has Performed in-line its overall industry.
Next quarter’s sales forecast for RVU is zł22.10M with a range of zł21.80M to zł22.40M. The previous quarter’s sales results were zł14.92M. RVU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.06% of the time in the same period. In the last calendar year RVU has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - OpenAI Analyst forecast on PL:RVU
TipRanks - OpenAI
TipRanks - OpenAI
zł27zł25
Sell
-9.58%
Downside
Downgraded
09/28/25
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on PL:RVU
TipRanks - PerPlexity
TipRanks - PerPlexity
zł27
Sell
-2.35%
Downside
Initiated
09/16/25
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on PL:RVU
TipRanks - Google
TipRanks - Google
zł27
Hold
-2.35%
Downside
Initiated
09/14/25
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on PL:RVU
TipRanks - xAI
TipRanks - xAI
zł28
Hold
1.27%
Upside
Initiated
09/14/25
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - OpenAI Analyst forecast on PL:RVU
TipRanks - OpenAI
TipRanks - OpenAI
zł27zł25
Sell
-9.58%
Downside
Downgraded
09/28/25
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on PL:RVU
TipRanks - PerPlexity
TipRanks - PerPlexity
zł27
Sell
-2.35%
Downside
Initiated
09/16/25
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on PL:RVU
TipRanks - Google
TipRanks - Google
zł27
Hold
-2.35%
Downside
Initiated
09/14/25
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on PL:RVU
TipRanks - xAI
TipRanks - xAI
zł28
Hold
1.27%
Upside
Initiated
09/14/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ryvu Therapeutics SA

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+6.40%
initiated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
1 Year
PerPlexity Health Care EUTipRanks - PerPlexity
Success Rate
1/1 ratings generated profit
100%
Average Return
+0.10%
initiated a sell rating 5 months ago
Copying PerPlexity Health Care EU's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +0.10% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+0.10%
initiated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +0.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RVU Analyst Recommendation Trends

Rating
Sep 25
Strong Buy
0
Buy
0
Hold
0
Sell
1
Strong Sell
0
total
1
In the current month, RVU has received 0 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. RVU average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

RVU Stock Forecast FAQ

What is PL:RVU’s average 12-month price target, according to analysts?
Currently, no data Available
What is PL:RVU’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for PL:RVU, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Ryvu Therapeutics SA a Buy, Sell or Hold?
      Currently, no data Available
      What is Ryvu Therapeutics SA’s share price target?
      Currently, no data Available
      What do analysts say about Ryvu Therapeutics SA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Ryvu Therapeutics SA?
      To buy shares of PL:RVU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.